Knowledge Zone
Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries
Recent news and posts
Laboratory test nomenclature updated in Finland
On April 18, 2024, the updated version of the Finnish Laboratory Tests Nomenclature was published by the Finnish Institute for Health and Welfare (THL) to come into force on May 1, 2024. The nomenclature is maintained by the Association of Local and Regional Authorities. It covers studies in clinical chemistry, clinical physiology, clinical microbiology, clinical neurophysiology, genetics, pathology, and functional diagnostic tests (such as spirometry or ECG) and is used to unify coding laboratory procedures in Finland. The Laboratory Tests Nomenclature is also used to code the tests in private settings with coverage from the national public payor (KELA).
A total of four new codes were introduced in the updated version concerning in-vitro diagnostics. Some examples of newly introduced codes are provided below:
- 6812 P-C-reactive protein, sensitive method;
- 6813 fP-Lipoprotein (a).
The letter before the code name specifies the sample type: P – plasma, fP – plasma from a fasting patient.
See the full details in Finnish here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.